Meiji Yasuda Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,986
| Closed | -$536K | – | 546 |
|
|
2025
Q1 | $536K | Hold |
1,986
| – | – | 0.02% | 423 |
|
|
2024
Q4 | $467K | Hold |
1,986
| – | – | 0.02% | 450 |
|
|
2024
Q3 | $546K | Sell |
1,986
-44
| -2% | -$12.1K | 0.02% | 422 |
|
|
2024
Q2 | $493K | Buy |
2,030
+270
| +15% | +$65.6K | 0.02% | 430 |
|
|
2024
Q1 | $263K | Buy |
1,760
+380
| +28% | +$56.8K | 0.01% | 573 |
|
|
2023
Q4 | $264K | Hold |
1,380
| – | – | 0.01% | 485 |
|
|
2023
Q3 | $244K | Buy |
1,380
+160
| +13% | +$28.3K | 0.01% | 553 |
|
|
2023
Q2 | $232K | Hold |
1,220
| – | – | 0.01% | 557 |
|
|
2023
Q1 | $244K | Buy |
1,220
+50
| +4% | +$10K | 0.01% | 534 |
|
|
2022
Q4 | $278 | Sell |
1,170
-50
| -4% | -$12 | 0.01% | 525 |
|
|
2022
Q3 | $244K | Sell |
1,220
-190
| -13% | -$38K | 0.01% | 538 |
|
|
2022
Q2 | $206K | Buy |
1,410
+160
| +13% | +$23.4K | 0.01% | 600 |
|
|
2022
Q1 | $204K | Sell |
1,250
-150
| -11% | -$24.5K | 0.01% | 601 |
|
|
2021
Q4 | $237K | Buy |
1,400
+160
| +13% | +$27.1K | 0.01% | 501 |
|
|
2021
Q3 | $234K | Buy |
1,240
+60
| +5% | +$11.3K | 0.02% | 473 |
|
|
2021
Q2 | $200K | Buy |
+1,180
| New | +$200K | 0.01% | 510 |
|
|
2020
Q3 | – | Sell |
-1,470
| Closed | -$218K | – | 374 |
|
|
2020
Q2 | $218K | Buy |
+1,470
| New | +$218K | 0.02% | 444 |
|